CAI - CIK 0002019410
Caris Life Sciences, Inc. (CAI) reported revenue of $812.03M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $812.03M | +97.0% |
| FY 2024 | $412.26M | +34.7% |
| FY 2023 | $306.13M | - |
Caris Life Sciences, Inc. (CAI) reported revenue of $812.03M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.